Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017

Evidence-based Complementary and Alternative Medicine

Volumn 2017, Issue , 2017, Pages

  Liu, Yanfei ^a,b   Sun, Mingyue ^b   Yao, Hezhi ^b   Liu, Yue ^b   Gao, Rui ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; HERBACEOUS AGENT; RADIX LITHOSPERMI; UNCLASSIFIED DRUG;

ASTRAGALUS MEMBRANACEUS; COPTIS; DRUG EFFICACY; DRUG MECHANISM; EPHEDRA SINICA; ETHNOPHARMACOLOGY; EVIDENCE BASED PRACTICE; GANODERMA LUCIDUM; GINSENG; HERBAL MEDICINE; HUMAN; LITHOSPERMUM; LITHOSPERMUM ERYTHRORHIZON; MEDLINE; NONHUMAN; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUM; RHUBARB; SAFFLOWER; TEA; TRIPTERYGIUM WILFORDII; WEB OF SCIENCE;

EID: 85031914821     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2017/8943059     Document Type: Review

References (86)

1. Y. C.Wang, K. McPherson, T. Marsh, S. L. Gortmaker, and M. Brown, "Health and economic burden of the projected obesity trends in the USA and the UK," The Lancet, vol. 378, no. 9793, pp. 815-825, 2011.
2. https://www.aace.com/sites/all/files/Obesity Guidelines Algorithm slides FINAL 2016.pdf.
3. The GBD 2015 Obesity Collaborators, "Health Effects of Overweight and Obesity in 195 Countries over 25 Years," New England Journal of Medicine, vol. 377, no. 1, pp. 13-27, 2017.
4. A. Obata, S. Okauchi, T. Kimura et al., "Advanced breast cancer in a relatively youngmanwith severe obesity and type 2 diabetes mellitus," Journal of Diabetes Investigation, vol. 8, no. 3, pp. 395-396, 2017.
5. M. Ng, T. Fleming, M. Robinson, and et al, "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013," The Lancet, vol. 384, no. 9945, pp. 766-781, 2014.
6. L. Landsberg, L. J. Aronne, L. J. Beilin et al., "Obesityrelated hypertension: Pathogenesis, cardiovascular risk, and treatment-a position paper of the obesity society and the American society of hypertension," Obesity, vol. 21, no. 1, pp. 8-24, 2013.
7. C. Arroyo-Johnson and K. D. Mincey, "Obesity Epidemiology Worldwide," Gastroenterology Clinics of North America, vol. 45, no. 4, pp. 571-579, 2016.
8. P. L. Lefèbvre and A. J. Scheen, "Obesity: Causes and new treatments," Experimental and Clinical Endocrinology and Diabetes, vol. 109, no. 2, pp. S215-S224, 2001.
9. C. M. Apovian, L. J. Aronne, D. H. Bessesen et al., "Pharmacological management of obesity: an endocrine society clinical practice guideline," Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 2, pp. 342-362, 2015.
10. M. O. Dietrich and T. L. Horvath, "Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons," Nature Reviews Drug Discovery, vol. 11, no. 9, pp. 675-691, 2012.
11. E. Mead, G. Atkinson, B. Richter et al., "Drug interventions for the treatment of obesity in children and adolescents," Cochrane Database of Systematic Reviews, vol. 29, no. 11, Article ID CD012436, 2016.
12. C. Van Der Schoor, H. M. Oberholzer, M. J. Bester, and M.-J. Van Rooy, "The effect of sibutramine, a serotoninnorepinephrine reuptake inhibitor, on platelets and fibrin networks of male Sprague-Dawley rats: A descriptive study," Ultrastructural Pathology, vol. 38, no. 6, pp. 399-405, 2014.
13. J. J. Kim, M. E. Tarnoff, and S. A. Shikora, "Surgical Treatment for Extreme Obesity: Evolution of a Rapidly Growing Field," Nutrition in Clinical Practice, vol. 18, no. 2, pp. 109-123, 2003.
14. S. Ikramuddin, J. Korner,W.-J. Lee et al., "Durability of addition of Roux-en-Y Gastric Bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: A randomized control trial," Diabetes Care, vol. 39, no. 9, pp. 1510-1518, 2016.
15. J. Y. Park and Y. J. Kim, "Laparoscopic Roux-en-Y gastric bypass in obese Korean patients: efficacy and potential adverse events," Surgery Today, vol. 46, no. 3, pp. 348-355, 2016.
16. J. E. Lambert, J. A. Parnell, J. M. Tunnicliffe, J.Han, T. Sturzenegger, and R. A. Reimer, "Consuming yellow pea fiber reduces voluntary energy intake and body fat in overweight/obese adults in a 12-week randomized controlled trial," Clinical Nutrition, 2015.
17. K. Azushima, K. Tamura, S. Haku et al., "Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: A multicenter, randomized, parallel-group controlled trial (ATHD-14-01021.R2)," Atherosclerosis, vol. 240, no. 1, pp. 297-304, 2015.
18. Q. Zhou, B. Chang, X.-Y. Chen et al., "Chinese herbal medicine for obesity:Arandomized, double-blinded,multicenter, prospective trial,"American Journal of ChineseMedicine, vol. 42, no. 6, pp. 1345-1356, 2014.
19. G. B. Lenon, K. X. Li, Y.-H. Chang et al., "Efficacy and safety of a Chinese herbal medicine formula (RCM-104) in the management of simple obesity: A randomized, placebocontrolled clinical trial," Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 435702, 2012.
20. B. Ke, L. Shi, J.-J. Zhang, D.-S. Chen, J. Meng, and J. Qin, "Protective effects ofModified Linggui ZhuganDecoction combined with short-term very low calorie diets on cardiovascular risk factors in obese patients with impaired glucose tolerance," Journal of Traditional Chinese Medicine, vol. 32, no. 2, pp. 193-198, 2012.
21. S.-L. Chu, H. Fu, J.-X. Yang et al., "A randomized double-blind placebo-controlled study of Pu'er tea extract on the regulation ofmetabolic syndrome,"Chinese Journal of IntegrativeMedicine, vol. 17, no. 7, pp. 492-498, 2011.
22. Z. Li, R. Song, C. Nguyen et al., "Pistachio nuts reduce triglycerides and body weight by comparison to refined carbohydrate snack in obese subjects on a 12-week weight loss program," Journal of the American College of Nutrition, vol. 29, no. 3, pp. 198-203, 2010.
23. M. Abidov, Z. Ramazanov, R. Seifulla, and S. Grachev, "The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat," Diabetes, Obesity and Metabolism, vol. 12, no. 1, pp. 72-81, 2010.
24. B. Gout, C. Bourges, and S. Paineau-Dubreuil, "Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women," Nutrition Research, vol. 30, no. 5, pp. 305-313, 2010.
25. E. A. Datau, Wardhana, E. E. Surachmanto, K. Pandelaki, J. A. Langi, and Fias, "Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male," Acta Medica Indonesiana, vol. 42, no. 3, pp. 130-134, 2010.
26. F. Di Pierro, A. B. Menghi, A. Barreca, M. Lucarelli, and A. Calandrelli, "GreenSelect phytosome as an adjunct to a lowcalorie diet for treatment of obesity: A clinical trial," Alternative Medicine Review, vol. 14, no. 2, pp. 154-160, 2009.
27. H. Wang, Y. Wen, Y. Du et al., "Effects of catechin enriched green tea on body composition," Obesity, vol. 18, no. 4, pp. 773-779, 2010.
28. R.-R. He, L. Chen, B.-H. Lin, Y. Matsui, X.-S. Yao, and H. Kurihara, "Beneficial effects of oolong tea consumption on dietinduced overweight and obese subjects," Chinese Journal of Integrative Medicine, vol. 15, no. 1, pp. 34-41, 2009.
29. J. L. Ngondi, B. C. Etoundi, C. B. Nyangono, C. M. F. Mbofung, and J. E. Oben, "IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation," Lipids in Health and Disease, vol. 8, article no. 7, 2009.
30. J. E. Oben, J. L. Ngondi, C. N. Momo, G. A. Agbor, and C. S. M. Sobgui, "The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: A double-blind placebo-controlled study," Lipids in Health and Disease, vol. 7, article no. 12, 2008.
31. C. Roongpisuthipong, R. Kantawan, andW. Roongpisuthipong, "Reduction of adipose tissue and body weight: effect of water soluble calcium hydroxycitrate in Garcinia atroviridis on the short term treatment of obese women in Thailand," Asia Pacific Journal of Clinical Nutrition, vol. 16, no. 1, pp. 25-29, 2007.
32. R. Kuriyan, T. Raj, S. K. Srinivas, M. Vaz, R. Rajendran, and A. V. Kurpad, "Effect of Caralluma Fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women," Appetite, vol. 48, no. 3, pp. 338-344, 2007.
33. J. E. Oben, D. M. Enyegue, G. I. Fomekong, Y. B. Soukontoua, and G. A. Agbor, "The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesityinduced oxidative stress," Lipids in Health and Disease, vol. 6, article no. 4, 2007.
34. W.-J.Ni, H.-H. Ding, and L.-Q. Tang, "Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms," European Journal of Pharmacology, vol. 760, pp. 103-112, 2015.
35. W. Xie, D. Gu, J. Li, K. Cui, and Y. Zhang, "Effects and action mechanisms of berberine and rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice," PLoS ONE, vol. 6, no. 9, Article ID e24520, 2011.
36. L. P. Christensen, "Chapter 1 ginsenosides: chemistry, biosynthesis, analysis, and potential health effects," Advances in Food and Nutrition Research, vol. 55, pp. 1-99, 2008.
37. S. A. Palaniyandi, J. W. Suh, and S. H. Yang, "Preparation of ginseng extract with enhanced levels of ginsenosides Rg1 and Rb1 using high hydrostatic pressure and polysaccharide hydrolases," PharmacognosyMagazine, vol. 13, 1,no. 49,pp. 142-147, 2017.
38. X.Zhang, J.Cui,Q. Meng, S. Li,W.Zhou, and S. Xiao, "Advance in anti-tumor mechanisms of shikonin, alkannin and their derivatives," Mini-Reviews in Medicinal Chemistry, vol. 17, no. 18, 2017.
39. X. Chen, L. Yang, J. J. Oppenheim, andO.M. Z.Howard, "Cellular pharmacology studies of shikonin derivatives," Phytotherapy Research, vol. 16, no. 3, pp. 199-209, 2002.
40. M. Su, W. Huang, and B. Zhu, "Acetylshikonin from Zicao prevents obesity in rats on a high-fat diet by inhibiting lipid accumulation and inducing lipolysis," PLoS ONE, vol. 11, no. 1, Article ID e0146884, 2016.
41. M.-L. Su, Y. He, Q.-S. Li, and B.-H. Zhu, "Efficacy of acetylshikonin in preventing obesity and hepatic steatosis in db/db mice," Molecules, vol. 21, no. 8, article 976, 2016.
42. A. Bettaieb, E. Hosein, S. Chahed et al., "Decreased adiposity and enhanced glucose tolerance in shikonin treated mice," Obesity, vol. 24, no. 5, pp. 2269-2277, 2016.
43. E. A. Abourashed, A. T. El-Alfy, I. A. Khan, and L. Walker, "Ephedra in perspective-a current review," Phytotherapy Research, vol. 17, no. 7, pp. 703-712, 2003.
44. J.-H. Wang, B.-S. Kim, K. Han, and H. Kim, "Ephedra-treated donor-derived gut microbiota transplantation ameliorates high fat diet-induced obesity in rats," International Journal of Environmental Research and Public Health, vol. 14, aricle 555, no. 6, 2017.
45. H. Lim, J. Park, H.-L. Kimet al., "Chrysophanic acid suppresses adipogenesis and induces thermogenesis by activating AMPactivated protein kinase alpha in vivo and in vitro," Frontiers in Pharmacology, vol. 4, article 476, no. 7, 2016.
46. J. Li, L. Ding, B. Song et al., "Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway," European Journal of Pharmacology, vol. 770, pp. 99-109, 2016.
47. D. Türközü and N. A. Tek, "A minireview of effects of green tea on energy expenditure," Critical Reviews in Food Science and Nutrition, vol. 57, no. 2, pp. 254-258, 2017.
48. J.-Y. Choi, Y. J. Kim, R. Ryu, S.-J. Cho, E.-Y. Kwon, and M.-S. Choi, "Effect of green tea extract on systemic metabolic homeostasis in diet-induced obese mice determined via RNAseq transcriptome profiles," Nutrients, vol. 8, no. 10, article no. 640, 2016.
49. A. Xu, H. Wang, R. L. C. Hoo et al., "Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice," Endocrinology, vol. 150, no. 2, pp. 625-633, 2009.
50. E. Christodoulou, N. P. Kadoglou, N. Kostomitsopoulos, and G. Valsami, "Saffron:Anatural productwith potential pharmaceutical applications," Journal of Pharmacy and Pharmacology, vol. 67, no. 12, pp. 1634-1649, 2015.
51. M. Mashmoul, A. Azlan, N. Mohtarrudin et al., "Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high-fat diet-induced obese rats," BMC Complementary and AlternativeMedicine, vol. 16, no. 1, article 401, 2016.
52. H. Zhu, X. Wang, H. Pan et al., "The mechanism by which safflower yellow decreases body fat mass and improves insulin sensitivity in HFD-induced obese mice," Frontiers in Pharmacology, vol. 7, no. MAY, article 127, 2016.
53. J. Liu, J. Lee, M. Salazar Hernandez, R. Mazitschek, and U. Ozcan, "Treatment of obesity with celastrol," Cell, vol. 161, no. 5, pp. 999-1011, 2015.
54. S. K.-Y. Law, M. P. Simmons, N. Techen et al., "Molecular analyses of the Chinese herb Leigongteng (Tripterygium wilfordii Hook.f.)," Phytochemistry, vol. 72, no. 1, pp. 21-26, 2011.
55. Chinese Pharmacopoeia Commission, Pharmacopoeia of the People's Republic of China, Chinese Medical Science Press, Beijing, China, 2010.
56. Z.-Y. Zou, Y.-R.Hu, H. Ma et al., "Coptisine attenuates obesityrelated inflammation through LPS/TLR-4-mediated signaling pathway in Syrian golden hamsters," Fitoterapia, vol. 105, pp. 139-146, 2015.
57. W.-L. Zhang, L. Zhu, and J.-G. Jiang, "Active ingredients from natural botanicals in the treatment of obesity," Obesity Reviews, vol. 15, no. 12, pp. 957-967, 2014.
58. J. S. Choi, J.-H. Kim, M. Y. Ali, B.-S.Min, G.-D. Kim, and H. A. Jung, "Coptis chinensis alkaloids exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating C/EBP-and PPAR-," Fitoterapia, vol. 98, pp. 199-208, 2014.
59. J. Zhang, H. Tang, R. Deng et al., "Berberine suppresses adipocyte differentiation via decreasing CREB transcriptional activity," PLoS ONE, vol. 10, no. 4, Article IDe0125667, 2015.
60. Y. Li, T. J. Zhang, S. X. Liu, R. R. Wang, and J. Luo, "Research on chemical compositions and pharmacology role of Gingeng," ChineseTraditional andHerbal Drugs, vol. 40, no. 1, pp. 164-166, 2009.
61. M. C. Kho, Y. J. Lee, J. H. Park et al., "Fermented red ginseng potentiates improvement of metabolic dysfunction in metabolic syndrome rat models," Nutrients, vol. 8, no. 6, article 369, 2016.
62. N. Karu, R. Reifen, and Z. Kerem, "Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor," Journal of Agricultural and Food Chemistry, vol. 55, no. 8, pp. 2824-2828, 2007.
63. E.-J. Koh, K.-J. Kim, J. Choi, H. J. Jeon, M.-J. Seo, and B.-Y. Lee, "Ginsenoside Rg1 suppresses early stage of adipocyte development via activation of C/EBP homologous protein-10 in 3T3-L1 and attenuates fat accumulation in high fat diet-induced obese zebrafish," Journal of Ginseng Research, 2015.
64. J.-M. Cheon, D.-I. Kim, and K.-S. Kim, "Insulin sensitivity improvement of fermented Korean red ginseng (Panax ginseng) mediated by insulin resistance hallmarks in old-aged ob/ob mice," Journal of Ginseng Research, vol. 39, no. 4, pp. 331-337, 2015.
65. X. Li, J. Luo, P. V. A. Babu et al., "Dietary supplementation of chinese ginseng prevents obesity and metabolic syndrome in high-fat diet-fed mice," Journal of Medicinal Food, vol. 17, no. 12, pp. 1287-1297, 2014.
66. N. Lin, D. Cai, D. Jin, Y. Chen, and J. Shi, "Ginseng panaxoside Rb1 reduces body weight in diet-induced obese mice," Cell Biochemistry and Biophysics, vol. 68, no. 1, pp. 189-194, 2014.
67. S.-H. Park, N. M. Phuc, J. Lee et al., "Identification of acetylshikonin as the novel CYP2J2 inhibitorwith anti-cancer activity in HepG2 cells," Phytomedicine, vol. 24, pp. 134-140, 2017.
68. Y. He, Q. Li, M. Su, W. Huang, and B. Zhu, "Acetylshikonin from Zicao exerts antifertility effects at high dose in rats by suppressing the secretion of GTH," Biochemical and Biophysical Research Communications, vol. 476, no. 4, pp. 560-565, 2016.
69. R. Gul, S. U. Jan, S. Faridullah, S. Sherani, and N. Jahan, "Preliminary Phytochemical Screening, Quantitative Analysis of Alkaloids, and Antioxidant Activity of Crude Plant Extracts from Ephedra intermedia Indigenous to Balochistan," Scientific World Journal, vol. 2017, Article ID 5873648, 2017.
70. M.-K. Song, J.-Y.Um, H.-J. Jang, and B.-C. Lee, "Beneficial effect of dietary Ephedra sinica on obesity and glucose intolerance in high-fat diet-fed mice," Experimental andTherapeuticMedicine, vol. 3, no. 4, pp. 707-712, 2012.
71. L. Liu, L. Fan, H. Chen, X. Chen, and Z. Hu, "Separation and determination of four active anthraquinones in Chinese herbal preparations by flow injection-capillary electrophoresis," Electrophoresis, vol. 26, no. 15, pp. 2999-3006, 2005.
72. C. Sampath, M.R.Rashid, S. Sang, and M.Ahmedna, "Green tea epigallocatechin 3-gallate alleviates hyperglycemia and reduces advanced glycation end products via nrf2 pathway in mice with high fat diet-induced obesity," Biomedicine and Pharmacotherapy, vol. 87, pp. 73-81, 2017.
73. M. Muenzner, N. Tappenbeck, F. Gembardt et al., "Green tea reduces body fat via upregulation of neprilysin," International Journal of Obesity, vol. 40, no. 12, pp. 1850-1855, 2016.
74. M. Cheng, X. Zhang, Y. Miao, J. Cao, Z. Wu, and P. Weng, "The modulatory effect of (-)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3"Me) on intestinal microbiota of high fat dietinduced obesity mice model," Food Research International, vol. 92, pp. 9-16, 2017.
75. X. Zhu, L. Yang, F. Xu, L. Lin, and G. Zheng, "Combination therapy with catechins and caffeine inhibits fat accumulation in 3T3-L1 cells," Experimental andTherapeuticMedicine, vol. 13, no. 2, pp. 688-694, 2017.
76. M. Yamashita, M. Kumazoe, Y. Nakamura et al., "The combination of green tea extract and eriodictyol inhibited high-fat/highsucrose diet-induced cholesterol upregulation is accompanied by suppression of cholesterol synthesis enzymes," Journal of Nutritional Science and Vitaminology, vol. 62, no. 4, pp. 249-256, 2016.
77. H. Li, F. Xu, P. Yang et al., "Systematic screening and characterization of prototype constituents and metabolites of total astragalosides using HPLC-ESI-IT-TOF-MSn after oral administration to rats," Journal of Pharmaceutical and Biomedical Analysis, vol. 142, pp. 102-112, 2017.
78. R. L. C. Hoo, J. Y. L. Wong, C. F. Qiao, A. Xu, H. X. Xu, and K. S. L. Lam, "The effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its antiinflammatory activity," Nutrition and Metabolism, vol. 7, article 67, 2010.
79. M. Mashmoul, A. Azlan, N. Mohtarrudin et al., "Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high-fat diet-induced obese rats," BMC Complementary and AlternativeMedicine, vol. 16, article 401, no. 1, 2016.
80. C. Chang, C. Lin, C. Lu et al., "Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota," Nature Communications, vol. 23, article 7489, no. 6, 2015.
81. A.Thyagarajan-Sahu, B. Lane, and D. Sliva, "ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK," BMC Complementary andAlternativeMedicine, vol. 11, article 74, 2011.
82. M. Li, X. Liu, Y. He et al., "Celastrol attenuates angiotensin II mediated human umbilical vein endothelial cells damage through activation ofNrf2/ERK1/2/Nox2 signal pathway," European Journal of Pharmacology, vol. 797, pp. 124-133, 2017.
83. M.Hu, Q. Luo, G. Alitongbieke et al., "Celastrol-inducedNur77 interaction with TRAF2 alleviates inflammation by promoting mitochondrial ubiquitination and autophagy," Molecular Cell, vol. 66, no. 1, pp. 141-153, 2017.
84. S. Zhao, F. Otieno, A. Akpan, and R. J. Moots, "Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the PharmacologicalManagement of Elderly Patients," Drugs and Aging, vol. 34, no. 4, pp. 255-264, 2017.
85. J. Najafian, M. Abdar-Esfahani, M. Arab-Momeni, and A. Akhavan-Tabib, "Safety of herbal medicine in treatment of weight loss," ARYA Atherosclerosis, vol. 10, no. 1, pp. 55-58, 2014.
86. J. Martel, D. M. Ojcius, C.-J. Chang et al., "Anti-obesogenic and antidiabetic effects of plants and mushrooms," Nature Reviews Endocrinology, vol. 13, no. 3, pp. 149-160, 2017.